Key result
Higher Lp(a) is linked to ~15% higher ASCVD risk across ages, yielding highest absolute risk in older adults.
Why the study?
Does high lipoprotein(a) increase the risk of ASCVD similarly across different age groups, including older adults (70-100 years)?
Cohort (n=103,341)
Does high lipoprotein(a) increase the risk of ASCVD similarly across different age groups, including older adults (70-100 years)?
Answers are grounded in this paper and cite their sources.
High lipoprotein(a) is associated with a similar relative risk increase for ASCVD across all adult age groups, but older adults (70-100 years) experience the highest absolute risk increase.
BACKGROUND: High lipoprotein(a) is considered a causal risk factor for atherosclerotic cardiovascular diseases (ASCVD); however, whether the association between lipoprotein(a) and ASCVD is different among older individuals (defined as 70–100 years of age) compared with younger individuals is unclear. We evaluated differences in risk of ASCVD associated with high lipoprotein(a) stratified by age and sex. METHODS: We included 57 899 women and 45 442 men aged 20 to 100 years from the Copenhagen General Population Study, of which 18 322 (18%) were aged 70 to 100 years. Age-stratified incidence rates and hazard ratios for ASCVD were estimated. Secondary analyses were additionally stratified by sex. RESULTS: During a median follow-up of 12.5 years (maximum, 19.1), 9091 individuals were diagnosed with ASCVD. ASCVD incidence increase per 50 mg/dL (105 nmol/L) higher lipoprotein(a) were 0.3 per 1000 person-years (95% CI, 0.2–0.4) for age 20 to 49 years, 0.8 (0.6–0.9) for age 50 to 59 years, 1.5 (1.2–1.7) for age 60 to 69 years, 2.7 (2.2–3.2) for age 70 to 79 years, and 4.5 per 1000 person-years (3.7–5.4) for age 80 to 100 years. For lipoprotein(a) of 70 to 89 mg/dL (148–190 nmol/L), such incidence increases were 2.7 for age 20 to 49 years, 7.1 for age 50 to 59 years, 13.3 for age 60 to 69 years, 24.4 for age 70 to 79 years, and 40.9 for age 80 to 100 years. Corresponding values for lipoprotein(a) of 90 to 426 mg/dL (191–924 nmol/L) were 3.2, 8.3, 15.6, 28.7, and 48, respectively. The above results were similar in women and men, but with the highest incidence increases in men. Hazard ratios per 50 mg/dL higher lipoprotein(a) were similar across all age groups and sexes, ranging from 1.12 to 1.18 ( P interaction : by age=0.48; by sex=0.74). CONCLUSIONS: In a contemporary primary prevention cohort, the relative risk increase of ASCVD with higher lipoprotein(a) levels was similar for individuals aged older (aged 70–100 years) and younger individuals, with the highest absolute risk in this older age group.
No takes yet. Share an insight, caveat, or question.
Jeevanathan et al. (2026) conducted a cohort in Atherosclerotic cardiovascular diseases (ASCVD) (n=103,341). High lipoprotein(a) vs. Lower lipoprotein(a) was evaluated on Atherosclerotic cardiovascular diseases (ASCVD) (HR 1.12-1.18). Higher lipoprotein(a) was associated with a similar relative risk increase for ASCVD across all ages, but absolute risk increases were highest in adults aged 70-100 years.
Synapse has enriched 10 related papers. Consider them for comparative context: